Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
100 studies found for:    VITREOUS DETACHMENT
Show Display Options
Rank Status Study
1 Completed Assessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous Detachment
Conditions: Vitreous Detachment;   Diabetic Retinopathy
Intervention: Drug: Vitrase
2 Unknown  Posterior Vitreous Detachment (PVD) Assessment During Dual Retinal Vein Occlusion (RVO) Lucentis Evaluations
Conditions: Retinal Vein Occlusion;   Posterior Vitreous Detachment
Intervention: Drug: Ranibizumab
3 Terminated Study to Evaluate Plasmin for the Creation of a Posterior Vitreous Detachment
Condition: Disorders Caused by Vitreo-retinal Traction.
Interventions: Drug: Plasmin;   Drug: Vehicle
4 Enrolling by invitation Annular Array Ultrasound in Ophthalmology
Conditions: Posterior Vitreous Detachment;   Diabetic Retinopathy
Intervention: Procedure: annular array ultrasound exam
5 Terminated A Study to Evaluate Plasmin for the Creation of a Posterior Vitreous Detachment (PVD)
Condition: Disorders Caused by Vitreo-retinal Traction.
Intervention: Drug: Plasmin
6 Recruiting Effect of Vitrectomy and Posterior Vitreous Detachment on Intravitreal Ranibizumab Pharmacokinetics
Condition: Age Related Macular Degeneration
Intervention: Drug: Ranibizumab
7 Completed YAG Vitreolysis for Floaters
Conditions: Weiss Ring;   Floaters;   Posterior Vitreous Detachment
Intervention: Procedure: YAG vitreolysis
8 Recruiting A Study to Evaluate the Efficacy and Safety of Ocriplasmin in Inducing Total PVD in Subjects With NPDR
Conditions: Diabetic Retinopathy;   Posterior Vitreous Detachment;   Disease Progression
Interventions: Drug: ocriplasmin 0.0625mg;   Drug: ocriplasmin 0.125mg;   Drug: Sham injection
9 Recruiting Effect on the Vitreous of the Not Complicated Surgery of the Cataract to the Emmetropic Patient
Conditions: Cataract;   Vitreous Detachment
Intervention: Procedure: Cataract surgery
10 Enrolling by invitation High-Frequency-Ultrasound Annular Arrays for Ophthalmic Imaging
Condition: Posterior Vitreous Detachment
Intervention: Procedure: Ultrasound examination
11 Completed
Has Results
A Study of the Safety and Efficacy of Microplasmin to Induce a Posterior Vitreous Detachment (MIVI III)
Condition: Vitrectomy
Interventions: Drug: Ocriplasmin 25µg;   Drug: Ocriplasmin 75µg;   Drug: Ocriplasmin 125µg;   Drug: Placebo
12 Completed
Has Results
A Study to Compare Multiple Doses Intravitreal Microplasmin for Treatment of Patients With Vitreomacular Traction (MIVI-IIt)
Condition: Vitreomacular Traction
Interventions: Drug: ocriplasmin;   Drug: Sham Comparator
13 Completed Clear Vision Study
Conditions: Posterior Vitreous Detachment;   Vitreous Floaters
Interventions: Procedure: Laser Ablation of Floaters;   Procedure: Sham Laser Treatment
14 Completed Partial Posterior Hyaloidectomy in Macular Surgery
Conditions: Retinal Break;   Retinal Detachment
Intervention: Procedure: Partial posterior hyaloidectomy (a modified procedure of vitrectomy)
15 Recruiting Vitreopapillary Interface and Optic Disc Morphology
Conditions: Posterior Vitreous Detachment;   Vitreomacular Traction;   Glaucoma;   Vitreopapillary Traction
Intervention: Other: OCT imaging/HRT imaging
16 Completed Intravitreal Ranibizumab in Exudative Age-related Macular Degeneration With Posterior Vitreomacular Adhesion
Condition: Neovascular Age-related Macular Degeneration
Intervention: Procedure: Intravitreal expansile gas and ranibizumab injection
17 Completed Evaluation of the Effect of Vitreous Composition Determined by Ultrasound and Optical Coherence Tomography (OCT) on Ranibizumab Therapy
Condition: Choroidal Neovascularization
Intervention: Drug: Ranibizumab
18 Completed Comparison of a Spectral OCT/SLO With the Stratus OCT for Imaging Various Retinal Pathologies
Conditions: Macular Hole;   RPE Detachment;   Epiretinal Membrane;   Posterior Vitreous Detachment
Intervention:
19 Recruiting A Clinical Trial Designed to Evaluate the Safety and Efficacy Study of Luminate® in Inducing PVD (Posterior Vitreous Detachment) in Non-Proliferative Diabetic Retinopathy
Condition: Non-Proliferative Diabetic Retinopathy
Interventions: Drug: 1.0mg Luminate®;   Drug: 2.0mg Luminate®;   Drug: 3.0mg Luminate®;   Other: Balanced Salt Solution for intravitreal injection in 0.10cc
20 Unknown  A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects
Condition: Diabetic Retinopathy
Intervention: Drug: Vitreosolve

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years